A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy, European Urology, vol.64, issue.6, pp.895-902, 2013. ,
DOI : 10.1016/j.eururo.2013.03.033
Synergistic action of image-guided radiotherapy and androgen deprivation therapy, Nature Reviews Urology, vol.34, issue.4, pp.193-204, 2015. ,
DOI : 10.1001/jama.280.11.969
Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study, The Lancet Oncology, vol.9, issue.4, pp.342-51, 2008. ,
DOI : 10.1016/S1470-2045(08)70076-7
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study, The Lancet Oncology, vol.15, issue.13, pp.1521-1553, 2014. ,
DOI : 10.1016/S1470-2045(14)71021-6
Hypoxic Prostate/Muscle Po2 Ratio Predicts for Outcome in Patients With Localized Prostate Cancer: Long-Term Results, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.3, pp.433-442, 2012. ,
DOI : 10.1016/j.ijrobp.2011.05.037
Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer, Clinical Cancer Research, vol.18, issue.7, pp.2108-141078, 2012. ,
DOI : 10.1158/1078-0432.CCR-11-2711
URL : http://clincancerres.aacrjournals.org/content/clincanres/18/7/2108.full.pdf
Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality, International Journal of Radiation Oncology*Biology*Physics, vol.47, issue.3, pp.551-60, 2000. ,
DOI : 10.1016/S0360-3016(00)00467-3
????Dose-painting??????: mythe ou r??alit?????, Cancer/Radioth??rapie, vol.14, issue.6-7, pp.554-62, 2010. ,
DOI : 10.1016/j.canrad.2010.06.005
Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer, Front Oncol, vol.6, p.24, 2016. ,
Imaging hypoxia to improve radiotherapy outcome, Nature Reviews Clinical Oncology, vol.42, issue.12, pp.674-87, 2012. ,
DOI : 10.1007/s00259-007-0522-2
Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients, International Journal of Radiation Oncology*Biology*Physics, vol.36, issue.2, pp.417-445, 1996. ,
DOI : 10.1016/S0360-3016(96)00325-2
Androgen Withdrawal in Patients Reduces Prostate Cancer Hypoxia: Implications for Disease Progression and Radiation Response, Cancer Research, vol.67, issue.13, pp.6022-50008, 1158. ,
DOI : 10.1158/0008-5472.CAN-07-0561
URL : http://cancerres.aacrjournals.org/content/canres/67/13/6022.full.pdf
Personalized precision radiotherapy by integration of multi-parametric functional and biological imaging in prostate cancer: A feasibility study, Zeitschrift f??r Medizinische Physik, vol.27, issue.1, pp.21-30, 2017. ,
DOI : 10.1016/j.zemedi.2016.02.002
Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques, European Journal of Nuclear Medicine and Molecular Imaging, vol.71, issue.10, pp.1816-1839, 2011. ,
DOI : 10.1016/j.ijrobp.2007.06.079
URL : http://europepmc.org/articles/pmc3259612?pdf=render
Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer, J Pathol Inform, vol.7, issue.3, pp.2153-3539, 2016. ,
Glucose transporter Glut-1 is detectable in peri-necrotic regions in many human tumor types but not normal tissues: Study using tissue microarrays, Annals of Anatomy - Anatomischer Anzeiger, vol.192, issue.3, pp.133-141, 2010. ,
DOI : 10.1016/j.aanat.2010.03.001
URL : http://researchonline.ljmu.ac.uk/2334/3/Glut-1%20TARP%202009.pdf
Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue, Journal of Cellular Biochemistry, vol.56, issue.2, pp.553-62, 2012. ,
DOI : 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7
Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: A pilot study in men with prostate cancer, International Journal of Radiation Biology, vol.39, issue.9, pp.805-818, 2009. ,
DOI : 10.1016/S0360-3016(97)00328-3
GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker, Clinics, vol.66, issue.6, pp.965-72, 2011. ,
DOI : 10.1590/S1807-59322011000600008
URL : http://www.scielo.br/pdf/clin/v66n6/08.pdf
An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: Implications for radioresistance, International Journal of Radiation Oncology*Biology*Physics, vol.65, issue.1, pp.91-100, 2006. ,
DOI : 10.1016/j.ijrobp.2005.11.044
Hypoxia in Prostate Cancer: Correlation of BOLD-MRI With Pimonidazole Immunohistochemistry???Initial Observations, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.4, pp.1065-71, 2007. ,
DOI : 10.1016/j.ijrobp.2007.01.018
Histopathology-derived modeling of prostate cancer tumor control probability: Implications for the dose to the tumor and the gland, Radiotherapy and Oncology, vol.119, issue.1, pp.97-103, 2016. ,
DOI : 10.1016/j.radonc.2016.02.015
Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens, European Journal of Nuclear Medicine and Molecular Imaging, vol.62, issue.6, pp.824-855, 2013. ,
DOI : 10.1016/j.ijrobp.2004.12.089
Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer, International Journal of Radiation Oncology*Biology*Physics, vol.58, issue.3, pp.750-757, 2004. ,
DOI : 10.1016/S0360-3016(03)01621-3
Intratumoral Hypoxia as the Genesis of Genetic Instability and Clinical Prognosis in Prostate Cancer, Adv Exp Med Biol, vol.772, pp.189-204978, 2014. ,
DOI : 10.1007/978-1-4614-5915-6_9
Pathological Predictors for Site of Local Recurrence After Radiotherapy for Prostate Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.3 ,
DOI : 10.1016/j.ijrobp.2011.05.035
, Int J Radiat Oncol Biol Phys, vol.82, pp.441-449, 2012.
Boosting imaging defined dominant prostatic tumors: A systematic review, Radiotherapy and Oncology, vol.107, issue.3, pp.274-81, 2013. ,
DOI : 10.1016/j.radonc.2013.04.027
Radiosensitization of prostate cancer cells by the dual PI3K ,
, Radiother Oncol, vol.106, pp.138-184, 2013.
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference, International Journal of Radiation Oncology*Biology*Physics, vol.65, issue.4, pp.965-74, 2006. ,
DOI : 10.1016/j.ijrobp.2006.04.029
Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study, PLOS ONE, vol.30, issue.9, p.155333, 2016. ,
DOI : 10.1371/journal.pone.0155333.s002
Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer, Radiotherapy and Oncology, vol.105, issue.1, pp.21-29, 2012. ,
DOI : 10.1016/j.radonc.2012.08.019
Comparative Study With New Accuracy Metrics for Target Volume Contouring in PET Image Guided Radiation Therapy, IEEE Transactions on Medical Imaging, vol.31, issue.11, pp.2006-2030, 2012. ,
DOI : 10.1109/TMI.2012.2202322
URL : https://hal.archives-ouvertes.fr/hal-00763488
PI-RADS Prostate Imaging ??? Reporting and Data System: 2015, Version 2, European Urology, vol.69, issue.1, pp.16-40, 2016. ,
DOI : 10.1016/j.eururo.2015.08.052
Role of endorectal MR imaging and MR spectroscopic imaging in defining treatable intraprostatic tumor foci in prostate cancer: Quantitative analysis of imaging contour compared to whole-mount histopathology, Radiotherapy and Oncology, vol.110, issue.2, pp.303-311, 2014. ,
DOI : 10.1016/j.radonc.2013.12.003
A Fuzzy Locally Adaptive Bayesian Segmentation Approach for Volume Determination in PET, IEEE Transactions on Medical Imaging, vol.28, issue.6, pp.881-93, 2008. ,
DOI : 10.1109/TMI.2008.2012036
URL : https://hal.archives-ouvertes.fr/inserm-00372910
,
, Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications, Int J Radiat Oncol Biol Phys, vol.77, pp.301-309, 2010.